DHFR and acute lymphoblastic leukemia: In the 1940s, the development of aminopterin, which was found to target dihydrofolate reductase (DHFR), a cytoplasmic enzyme involved in one-carbon folate metabolism, yielded the first remission in a child with acute lymphoblastic leukemia (ALL) [2].